Drug Shortage Report for MYLAN-ATOVAQUONE/PROGUANIL
| Report ID | 255409 |
| Drug Identification Number | 02402165 |
| Brand name | MYLAN-ATOVAQUONE/PROGUANIL |
| Common or Proper name | ATOVAQUONE/PROGUANIL |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | PROGUANIL HYDROCHLORIDE ATOVAQUONE |
| Strength(s) | 100MG 250MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100BT |
| ATC code | P01BB |
| ATC description | ANTIMALARIALS |
| Reason for shortage | Shortage of an active ingredient. |
| Anticipated start date | 2025-05-05 |
| Actual start date | 2025-05-05 |
| Estimated end date | 2025-10-20 |
| Actual end date | 2025-10-20 |
| Shortage status | Resolved |
| Updated date | 2025-10-28 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.